1. Home
  2. NTWK vs EVAX Comparison

NTWK vs EVAX Comparison

Compare NTWK & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NetSol Technologies Inc.

NTWK

NetSol Technologies Inc.

HOLD

Current Price

$3.28

Market Cap

34.2M

Sector

Technology

ML Signal

HOLD

EVAX

Evaxion Biotech

HOLD

Current Price

$4.01

Market Cap

33.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTWK
EVAX
Founded
1997
2008
Country
United States
Denmark
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.2M
33.7M
IPO Year
1998
2021

Fundamental Metrics

Financial Performance
Metric
NTWK
EVAX
Price
$3.28
$4.01
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$12.33
AVG Volume (30 Days)
27.4K
68.2K
Earning Date
02-12-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.04
N/A
Revenue
$66,501,654.00
$7,650,000.00
Revenue This Year
N/A
$128.77
Revenue Next Year
N/A
N/A
P/E Ratio
$77.39
N/A
Revenue Growth
7.70
132.17
52 Week Low
$2.14
$1.20
52 Week High
$5.75
$12.15

Technical Indicators

Market Signals
Indicator
NTWK
EVAX
Relative Strength Index (RSI) 54.85 34.64
Support Level $3.02 $3.88
Resistance Level $3.17 $4.85
Average True Range (ATR) 0.15 0.36
MACD 0.02 -0.09
Stochastic Oscillator 55.43 8.13

Price Performance

Historical Comparison
NTWK
EVAX

About NTWK NetSol Technologies Inc.

NETSOL Technologies Inc is an information technology and enterprise software solutions provider to original equipment manufacturers (OEMs), dealerships, and financial institutions to sell, finance, and lease assets. The firm's products include Transcend Retail, Transcend Finance, Transcend Marketplace, Transcend Consultancy, and Transcend AI Labs, catering to its customers in the different stages of how assets are sold, financed, and leased. Its primary sources of revenue are licensing, subscriptions, modification, enhancement, and support of its suite of financial applications offered to businesses in the finance and leasing space, as well as automotive digital retail. The company has three reportable segments: Asia-Pacific, its key revenue-generating market, North America, and Europe.

About EVAX Evaxion Biotech

Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.

Share on Social Networks: